Additionally, low dose TBI did not increase the expression of the major histocompatibility complex (MHC) class II (Fig. 7c) or the co-stimulatory molecule CD80 on tumor resident DCs (Fig. 7d) or DCs located in the spleen or draining lymph nodes. This evidence concerns the gene HLA-C and neoplasm.